The global dental sleep medicine is expected to reach USD 10,851.03 million by the year 2023. The market is forecasted to demonstrate a steady growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period 2017 – 2023.
Dental sleep medicine is an area of dental practice which focuses on the use of oral appliances, therapies and drug treatment for the treatment of sleep-disorders affecting breathing such as snoring, upper airway resistance syndrome (UARS), bruxism and sleep apnea. Global dental sleep medicine market is witnessing profound growth due to factors such as sedentary lifestyles, noise and light pollution, increasing substance abuse, rise in obesity and growth of diseases such as atrial fibrillation, gastro esophageal reflux disease (GERD) etc. which affect the breathing rate and tone of muscles surrounding the air tract. However, unmet medical needs and the growing awareness and screening for sleep disorders is the most critical market driver. However, high cost of devices and the low efficacy and high failure rate of drugs and surgery may hamper the growth of the market. Scanty presence of sleep diagnostic labs and clinics. The low number of these labs results in higher costs to a few patients they serve. The PAPs cost about $1,600-$4,000 depending on the make and model of the machine. The PAP is prone to breakdown and the reimbursement for them is poor. Oral and nasal devices become worn out due to use and Bruxism (grinding of teeth and clenching of jaws). Reimbursement for second or third time is mostly not available. The major reason hampering the growth of the market.
Get a sample report at https://www.marketresearchfuture.com/sample_request/3021 .
Global Dental Sleep Medicine – Competitive Analysis
Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Curative Medical Inc., Apex Medical Corporation, BMC Medical Co. Ltd., Becton, Dickinson and Company are some of the prominent players at the forefront of competition in the Global Dental Sleep Medicine and are profiled in MRFR Analysis.
Characterized by the presence of several well-established and small players, the global market of dental sleep medicine appears to be highly competitive and fragmented. With well-established market in the North America region major companies have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover, the other small and medium scale players are generating revenue from local market.
For the dental sleep medicine market companies are following the strategic move of acquiring various others small and medium based companies. Adding to this Philips head quartered in the Netherlands, is one of the global leader in health technology. The company in March 2017, announced the acquisition of an Australian Pharmacy Sleep Services (APSS). Australian Pharmacy Sleep Services headquartered in Sidney is a pioneer in pharmacy sleep testing. This acquisition of APSS will enhance the Philips’ sleep and respiratory care offering and further will simultaneously support to enhance the business’ home sleep testing offering via the pharmacy channel in Australia.
Furthermore, in adding to this acquisition strategy DeVilbiss headquartered in Elland, United Kingdom announced the acquisition of Sidhil Group Limited on January 2017. Sidhil Group Limited is huge manufacture of healthcare products in United Kingdom for more than 130 year. This acquisition will enhances DeVilbiss existing manufacturing capabilities in the United Kingdom. Moreover this acquisition will enlarge the current product portfolio and increase the presence of DeVilbiss in the growing hospital, long-term care and homecare markets, with expanding the manufacturing footprint.
Global Dental Sleep Medicine – Regional Analysis
The global market is segmented into the various regions including North Americas, Europe, Asia Pacific, and the Middle East & Africa. North America is the most dominant region in the global dental sleep market. Rapid uptake of technology and presence of major dominant players in the dental sleep device manufacturing are the factors behind the dominance of North America. However the recent reimbursement policy chances from a fixed to competitive rates has resulted in the shrinking of profits for many sleep disorder devices. Europe captures the second position followed by Asia Pacific region which is the fastest growing region. The Asia pacific region is dominated by China which has emerged both as a large manufacturing base and also the largest market of Asia Pacific.
Browse Complete Report at https://www.marketresearchfuture.com/reports/dental-sleep-medicine-market-3021 .
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
P: +1 646 845 9312